Published: 31 March 2016
Issue 122 of Respiratory Research Review with a focus on venous thromboembolic disease and PAH (pulmonary arterial hypertension).
• COPD and VTE risk/mortality in a general population.
• Cancer-associated VTE: stopping anticoagulation on cancer cure.
• Selexipag improves PAH outcomes.
• 5-year outcomes of REVEAL registry patients.